ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 566

Rheumatoid Arthritis Patients’ Ability to Accurately Recall DMARD Information Immediately Following an Office Visit with Their Rheumatologist

Delesha Carpenter1, Lorie Geryk2, Courtney Roberts2, Beth L. Jonas3 and Susan J. Blalock4, 1Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville, NC, 2Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, 3Thurston Arthritis Research Ct, University of North Carolina Thruston Arthritis Research Center, Chapel Hill, NC, 4Eshelman School of Pharmacy, UNC at Chapel Hill, Chapel Hill, NC

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Communication, DMARDs, health literacy and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - ARHP Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Patient misunderstandings about DMARDs may contribute to nonadherence. We present longitudinal observational data regarding whether patients can accurately recall medication information about a newly-prescribed DMARD immediately after a rheumatology office visit and whether this is associated with DMARD prescription filling behavior one week after the office visit.

Methods: We recruited a convenience sample of 38 adult English-speaking RA patients who were prescribed a new self-administered DMARD from one rheumatology clinic in a southeastern state. The office visit during which the new DMARD was prescribed was audiotape recorded. Immediately after this visit, patients completed a demographic survey and were asked to recall what their rheumatologist said about how to take the DMARD and its benefits, side effects, and risks. Office visits and patient interviews were transcribed verbatim. Two independent coders who were blinded to study hypotheses compared what the rheumatologist said during the office visit to what the patient recalled for 15 different medication topics (Table 1). Coders recorded whether the rheumatologist discussed this topic during the visit and whether the patient’s recall of what the rheumatologist said was accurate (yes/no). Inter-reliability for the 15 topics was 0.89. We calculated descriptive statistics and examined bivariate associations to determine correlates of the patient inaccurately recalling (yes/no) any medication information (α=0.05).

Results: Participants were primarily women (87%) and white (71%). The mean age and disease duration were 49.1 (SD=13.4) and 9.4 years (SD=9.4), respectively. Only 12 (20%) patients were receiving a DMARD prescription for the first time. Nineteen patients (50%) inaccurately recalled information about at least one medication topic immediately after their office visit. Table 1 presents our study results. Patients with inaccurate recall had a longer disease duration (t(36)=-3.4, p=0.02), lower health literacy (χ2=7.1; p<0.01), and a lower household income (<$25,000 annually) (χ2=4.5; p=0.03). Patients with inaccurate recall were not less likely to get their prescription filled at 1-week follow-up (χ2=2.6; p=0.11).

Conclusion: Half of patients inaccurately recalled medication information about a newly-prescribed DMARD immediately after their rheumatology office visit. A number of DMARD topics were not explicitly discussed during the office visit, but may have been discussed in previous visits. Patients with low health literacy, lower household income, and longer disease duration were more likely to inaccurately recall DMARD information.

Table 1: Characteristics of rheumatology office visits during which a new DMARD was prescribed

Topic Rheumatologist Did Not Discuss Topic During Office Visit N (%) Patient Did Not Accurately Recall Information About Topic N (%) Examples of Inaccurate Recall
Long-term effectiveness of DMARD 30(79%) 0 –
How long patient should take DMARD (duration) 19(50%) 0 –
DMARD-other drug interactions 16(42%) 0 –
Contraindications 16(42%) 0 –
Costs of DMARD 12(32%) 0 –
Time until DMARD begins to take effect 11(29%) 2(5%) Patient said it might take two weeks to see improvement when doctor said three months.
Timing to take DMARD 8(21%) 1(3%) Patient said medication should be taken in afternoon when doctor said night.
Dosage 8(21%) 1(3%) Patient says they are supposed to take 1 pill/day and doctor said 4 pills/day.
Severity of side effects 7(18%) 0 –
Mechanism of action 6(16%) 2(5%) Patient said medication would stop cells from eating the bone in their body when doctor said it would reduce inflammation.
How to take DMARD 3(8%) 2(5%) Patient said doctor didn’t say how medication was supposed to be taken when doctor said it should be taken orally.
How often to take DMARD (frequency) 1(3%) 2(5%) Patient said they should take pill daily when doctor said it should be taken one day per week.
Benefits of DMARD 1(3%) 10(26%) Patient lists benefits of medication that were not discussed by doctor.
Side effect risk reduction strategies 1(3%) 5(13%) Patient mentions having to engage in risk reduction strategies that were not recommended by doctor.
Side effects of DMARD 0 5(13%) Patient lists kidney damage as side effect of medication when doctor did not mention kidney damage as side effect.

 


Disclosure: D. Carpenter, Arthritis Foundation, 2; L. Geryk, None; C. Roberts, None; B. L. Jonas, None; S. J. Blalock, None.

To cite this abstract in AMA style:

Carpenter D, Geryk L, Roberts C, Jonas BL, Blalock SJ. Rheumatoid Arthritis Patients’ Ability to Accurately Recall DMARD Information Immediately Following an Office Visit with Their Rheumatologist [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/rheumatoid-arthritis-patients-ability-to-accurately-recall-dmard-information-immediately-following-an-office-visit-with-their-rheumatologist/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-patients-ability-to-accurately-recall-dmard-information-immediately-following-an-office-visit-with-their-rheumatologist/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology